Zantac recall for ranitidine grows to include another medication

On Behalf of | Apr 22, 2020 | Zantac Recall

People across the country and here in Ohio continue to suffer from gastrointestinal ailments such as ulcers and acid reflux despite the recent removal of medications containing ranitidine from the market. In the wake of the Zantac recall, people turned to other medications to deal with these ailments. The problem is that now people may have to find yet another alternative to treat these conditions due to the recall of yet another medication.

This time, the medication involved is nizatidine. Amneal Pharmaceuitcals, LLC’s subsidiary, Gemini Laboratories LLC, distributes an oral solution containing this ranitidine alternative. Recent tests indicate that it, too, contains higher levels of N-Nitrosodimethylamine than the Food and Drug Administration allows. Amneal issued a recall for three lots of the medication in question, which had made its way to consumers.

The medication lots included in the recall were distributed across the country, which means at least some of it could have made it here to Ohio. Consumers are urged to quit taking the medication immediately and pharmacies are advised to remove the medication from circulation and quarantine it. So far, the company has not received any reports of adverse events, but as is the case with the ranitidine recalls, it could be some time before individuals suffer an illness related to NDMA.

After all the information provided during the Zantac recall, consumers more than likely know what to do at this point. Those relying on this company’s nizatidine oral solution will need to contact their doctors to find yet another alternative. Those who believe they suffered some sort of health issue may want to contact an experienced attorney to discuss their rights and available legal options.


What to do after a mesothelioma diagnosis
How to fund the war against opioid addiction in your community